Matinas BioPharma CFO Keith Kucinski to resign effective Jan 17, 2026

Matinas BioPharma Holdings, Inc.

Keith Kucinski notified his resignation as CFO on Nov 18, 2025.
Resignation effective Jan 17, 2026; he is pursuing other opportunities.
No disagreement with the Company regarding operations, policies, or practices.
No successor named; CEO Jerome Jabbour signed the filing.

item 5.02

Matinas BioPharma Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-024691

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.